TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously
Clinical trial NCT00513513 · TERMINATED
Trial details
- NCT number
- NCT00513513
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2007-09-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.